Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MRPS9 antisense RNA 2 (MRPS9-AS2) is an antisense long non-coding RNA gene located on human chromosome 2, annotated primarily in locus-based gene databases including NCBI and Ensembl[1]. There is no evidence from current literature or gene databases that MRPS9-AS2 is a therapeutic target, has a defined biological function, or is involved in disease mechanisms. The primary protein-coding gene in this region, MRPS9 (Mitochondrial ribosomal protein S9), is distinct and encodes a protein involved in mitochondrial ribosome structure and function[3][7]. MRPS9 itself, but not MRPS9-AS2, is implicated in disease and therapeutic contexts, including cancer biomarker studies and mitochondrial physiology[2][3][4][7]. No structured information, validated aliases, molecular functions, disease roles, or drug interactions are indicated for MRPS9-AS2. This suggests either limited knowledge, a potential misspelling, or an incorrect identification as a target; MRPS9-AS2 is not considered a validated therapeutic target[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MRPS9 antisense RNA 2 (MRPS9-AS2).